Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature

Batu, EZGİ; Sonmez, HAFİZE; HAZIROLAN, TUNCAY; ÖZALTIN, FATİH; BİLGİNER, YELDA; ÖZEN, SEZA

doi:10.1016/j.semarthrit.2016.07.012

Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature

Copy For Citation

Batu E. D., Sonmez H. E., HAZIROLAN T., ÖZALTIN F., BİLGİNER Y., ÖZEN S.

SEMINARS IN ARTHRITIS AND RHEUMATISM, vol.46, no.4, pp.529-535, 2017 (SCI-Expanded)

Publication Type: Article / Review
Volume: 46 Issue: 4
Publication Date: 2017
Doi Number: 10.1016/j.semarthrit.2016.07.012
Journal Name: SEMINARS IN ARTHRITIS AND RHEUMATISM
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.529-535
Keywords: Child, Takayasu arteritis, Tocilizumab, Treatment, RHEUMATOLOGY 1990 CRITERIA, DISEASE-ACTIVITY, TNF-ALPHA, CLASSIFICATION, CHILDREN, EFFICACY, INTERLEUKIN-6, VASCULITIS
Hacettepe University Affiliated: Yes

Abstract

Objective: Our aim was to describe our experience with tocilizumab (interleukin 6 receptor antagonist) treatment in children with Takayasu arteritis and to review previous studies regarding tocilizumab use in Takayasu arteritis patients.